Kaplan–Meier survival analysis showed that high PAR1 expression exhibited shorter relapse-free survival (RFS) in ER-negative and Grade 3 breast cancer that are more aggressive than ER-positive and low-grade breast cancer (Fig. 6f, g). The gene discussed is F2R; the disease is breast cancer.